Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Azenta, Inc. AZTA

Healthcare  —  Medical Instruments & Supplies
34.02 (0.18) (0.53%) as of 25 Sep
Market cap
$1.5B
P/E
0.0×
Dividend Champion (10y) Cash Flow Champion (3y) Insider Buys (last 12m)
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Azenta, Inc. (AZTA) Business Profile

Updated before January 2025

Company Overview

Azenta, Inc. (NASDAQ: AZTA) is a leading provider of life sciences solutions, specializing in sample management and genomic services. The company was originally founded in 1978 as Brooks Automation, Inc., focusing on automation and cryogenic solutions for the semiconductor industry. In 2021, the company rebranded to Azenta, Inc. to reflect its strategic pivot toward life sciences. Headquartered in Chelmsford, Massachusetts, Azenta operates globally, serving pharmaceutical, biotech, academic, and healthcare institutions.

Azenta’s leadership team is spearheaded by President and CEO Steve Schwartz, who has been instrumental in driving the company’s transformation into a life sciences powerhouse. The company’s board of directors and executive team bring decades of experience in technology, healthcare, and business strategy, ensuring a strong foundation for growth and innovation.

Core Business Segments

Azenta operates through two primary business segments: Sample Management Solutions and Genomic Services.

Sample Management Solutions

Azenta is a global leader in sample management, offering end-to-end solutions for the storage, transportation, and management of biological samples. Key offerings include:

  • Automated Storage Systems: Advanced robotic systems for storing and retrieving biological samples with precision and efficiency.
  • Cryogenic Storage Solutions: State-of-the-art cryogenic freezers and storage systems designed to preserve biological samples at ultra-low temperatures.
  • Sample Transport Services: Secure and temperature-controlled logistics solutions for transporting biological materials globally.
  • Sample Management Software: Proprietary software platforms that enable clients to track, manage, and analyze their sample inventories.

Genomic Services

Azenta provides comprehensive genomic services to support research and development in life sciences. Key offerings include:

  • Next-Generation Sequencing (NGS): High-throughput sequencing services for applications such as genomics, transcriptomics, and epigenomics.
  • Sanger Sequencing: Reliable and cost-effective sequencing for smaller-scale projects.
  • Gene Synthesis and Editing: Custom DNA synthesis and CRISPR-based gene editing services.
  • Biobanking Services: Long-term storage and management of biological samples for research and clinical use.

Business Model

Azenta’s business model is centered on providing integrated solutions that combine products, services, and software to meet the needs of life sciences organizations. The company generates revenue through the sale of its sample management systems, genomic services, and associated software solutions. Azenta also offers subscription-based models for its software platforms and long-term storage services, creating recurring revenue streams.

By leveraging its expertise in automation, cryogenics, and genomics, Azenta delivers value to its customers by improving the efficiency, accuracy, and reliability of their research and development processes. The company’s global footprint and robust supply chain enable it to serve clients across diverse geographies and industries.

Strategic Direction

Azenta is focused on expanding its presence in the life sciences sector through innovation, strategic acquisitions, and sustainability initiatives. Key strategic priorities include:

  • Service Expansion: Increasing the range and depth of genomic services offered, including advanced sequencing and gene editing technologies.
  • Geographic Growth: Expanding operations in emerging markets to tap into growing demand for life sciences solutions.
  • Sustainability Goals: Implementing eco-friendly practices in manufacturing and operations, including energy-efficient storage systems and reduced carbon emissions.
  • Product Innovation: Developing next-generation sample management systems and software platforms to address evolving customer needs.

Competitive Landscape

Azenta operates in a competitive market, facing challenges from both established players and emerging startups. Key competitors include:

  • Thermo Fisher Scientific: A global leader in life sciences solutions, offering a broad portfolio of products and services.
  • QIAGEN: Specializes in sample preparation and genomic analysis solutions.
  • Hamilton Storage: Focuses on automated storage systems for biological samples.
  • Beckman Coulter Life Sciences: Provides laboratory automation and genomic analysis tools.

Despite the competition, Azenta differentiates itself through its integrated approach, combining hardware, software, and services to deliver comprehensive solutions.

Risk Factors

Azenta faces several risks that could impact its business operations and financial performance:

  • Market Dependence: A significant portion of revenue is derived from the life sciences sector, making the company vulnerable to fluctuations in research funding and healthcare budgets.
  • Supply Chain Disruptions: Global supply chain challenges, including shortages of critical components, could delay product deliveries and increase costs.
  • Technological Obsolescence: Rapid advancements in technology require continuous innovation to stay competitive.
  • Regulatory Compliance: Stringent regulations in the life sciences industry could increase operational complexity and costs.

Recent Developments

Azenta has made significant strides in recent years, including:

  • Acquisitions: The company has acquired several genomic services firms to enhance its capabilities and expand its customer base.
  • Product Launches: Introduction of advanced cryogenic storage systems and next-generation sequencing services.
  • Global Expansion: Establishment of new facilities in Asia and Europe to support growing demand.
  • Sustainability Initiatives: Implementation of energy-efficient manufacturing processes and eco-friendly packaging solutions.

Investment Considerations

Investors considering Azenta should weigh the following strengths and risks:

Strengths

  • Strong market position in sample management and genomic services.
  • Diversified revenue streams from products, services, and software.
  • Robust growth potential in the life sciences sector.
  • Commitment to innovation and sustainability.

Risks

  • Dependence on a single industry sector.
  • Exposure to global supply chain disruptions.
  • High competition from established players.
  • Regulatory and compliance challenges.

Conclusion

Azenta, Inc. is well-positioned to capitalize on the growing demand for life sciences solutions, thanks to its innovative products, comprehensive services, and strategic focus on sustainability. While the company faces challenges such as market dependence and supply chain risks, its strong leadership and commitment to innovation provide a solid foundation for future growth. As the life sciences sector continues to expand, Azenta is poised to play a pivotal role in advancing research and development globally.